Bernadette Wildemore, MD
Pathologist
Asbestosis Diffuse Pleural Thickening Laryngeal Cancer Lung Cancer Ovarian Cancer Pericardial Mesothelioma Peritoneal Mesothelioma Pleural Effusions Pleural Mesothelioma Pleural Plaques Pleuritis Rounded Atelectasis Testicular Mesothelioma
Cancer Antigen 125, CA Fibulin-3 Human MPF ELISA Kit Mesomark Osteopontin SOMAmer Panel
Dr. Bernadette Wildemore is a pathologist from Suwanee, Georgia. She got her diploma from Sidney Kimmel Medical College and did her residency in Medical Genetics at University of North Carolina Hospitals and Anatomic and Clinical Pathology at Thomas Jefferson University. Dr. Bernadette Wildemore did a fellowship in Molecular Genetic Pathology at Harvard Medical School. The doctor has an experience of more than 20 years.
Sidney Kimmel Medical College
Medical School
University of North Carolina Hospitals
Residency
Thomas Jefferson University
Residency
Harvard Medical School
Fellowship
PA State Medical License Active through 2018
MA State Medical License Active through 2017
GA State Medical License Active through 2017
NC State Medical License Active through 2017
AL State Medical License Active through 2017
SC State Medical License Active through 2017
TN State Medical License Active through 2018
AZ State Medical License Active through 2018
CA State Medical License Active through 2018
FL State Medical License Active through 2018
IL State Medical License Active through 2017
NY State Medical License Active through 2018
NJ State Medical License Active through 2017
Mitostatin is down-regulated in human prostate cancer and suppresses the invasive phenotype of prostate cancer cells.
Fassan M, D'Arca D, Letko J, Vecchione A, Gardiman MP, McCue P, Wildemore B, Rugge M, Shupp-Byrne D, Gomella LG, Morrione A, Iozzo RV, Baffa R; PLoS One. 2011 May 06.
See more >>Prevention of urinary bladder cancer in the FHIT knock-out mouse with Rofecoxib, a Cox-2 inhibitor.
D'Arca D, LeNoir J, Wildemore B, Gottardo F, Bragantini E, Shupp-Byrne D, Zanesi N, Fassan M, Croce CM, Gomella LG, Baffa R; Urol Oncol. 2010 Mar-Apr.
See more >>Deficient DNA mismatch repair is common in Lynch syndrome-associated colorectal adenomas.
Pino, M.S., Mino-Kenudson, M., Wildemore, B.M., Ganguly, A., Batten, J., Sperduti, I., Iafrate, A.J., Chung, D.C.; J Mol Diagn. 2009 May.
See more >>